Genmab A/S
GNMSF
$241.84
-$3.16-1.29%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 57.64% | 42.50% | 78.38% | 13.24% | 24.50% |
| Total Depreciation and Amortization | 35.89% | 18.92% | 39.55% | -8.94% | 0.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -216.67% | -30.69% | -78.66% | 51.65% | -10.45% |
| Change in Net Operating Assets | -129.56% | 40.21% | -156.04% | -1,149.44% | -42.53% |
| Cash from Operations | 6.07% | 45.23% | 5.29% | 11.00% | 14.79% |
| Capital Expenditure | -28.29% | 16.90% | 49.13% | 60.27% | 42.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -83.57% | 255.94% | 380.83% | 456.50% | 199.50% |
| Cash from Investing | 101.99% | -221.31% | -669.22% | -968.01% | -193.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 51.06% | 69.86% | 74.73% | 47.83% | 49.46% |
| Issuance of Common Stock | 1.67% | -55.81% | -57.24% | -79.74% | -82.81% |
| Repurchase of Common Stock | -35.19% | -459.56% | -25.94% | -24.70% | 60.61% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 12.57% | -485.57% | -547.71% | -760.62% | -236.77% |
| Foreign Exchange rate Adjustments | 300.82% | 329.55% | 224.23% | 6.42% | 22.99% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.49% | -256.49% | -208.68% | -311.11% | -775.68% |